Tokyo, Japan – October 29, 2018 – LPixel Inc., a leader in image analysis and processing technology in life science and medical research, has announced today that it has entered a business alliance agreement with CYBERDYNE INC., the Japanese robotics company noted for marketing and distributing the HAL robotics exoskeleton suit.
CYBERDYNE, well-known for HAL and Vital Sensor, is the developer of various Cybernic Devices and Interfaces designed to acquire physical and vital data from its users. The information collected from these devices come together to form big data, which CYBERDYNE utilizes for developing methods that promote the early detection, diagnosis, and treatment of various diseases. With aims to develop innovative medical technologies that leverages medical image big data, LPixel has formed an alliance with CYBERDYNE to unify its AI medical image diagnostic support technologies with those of CYBERDYNE. The two companies will jointly promote the creation of the cybernics industry, which is a functional, organic and social integration of “people,” “machine,” and “information systems.”
About CYBERDYNE, INC.
Since its establishment as a venture company from the University of Tsukuba in 2004, CYBERDYNE has promoted the comprehensive development of various Cybernic Systems (Cybernic devices, Cybernic interfaces, etc.) that utilize Cybernic Technology from research and development to social implementation, aiming to tackle the various issues the society is facing. The company has developed business in the fields of medicine, living support and daily living (including the work environment), and its main product, Robot Suit HAL is widely distributed not only in the medical and living support fields but also in care support and labor support fields. In addition, new products such as Transportation Robot and Cleaning Robot equipped with artificial intelligence and environment recognition functions, HAL Lumbar Type for reduction of the load and stress on the lower back, smaller-sized HAL (Single-Joint Type), Vital Sensor for arteriosclerosis and arrhythmia measurements are continuously developed. For more details, please refer to the following website: https://www.cyberdyne.jp/eng/